Skip to main content

Peer Review reports

From: Chalcone/1,3,4-Oxadiazole/Benzimidazole hybrids as novel anti-proliferative agents inducing apoptosis and inhibiting EGFR & BRAFV600E

Original Submission
6 Mar 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
2 Apr 2023 Reviewed Reviewer Report - Magda H. Abdellattif
6 Apr 2023 Reviewed Reviewer Report
6 May 2023 Author responded Author comments - Dalia Abdelhamid
Resubmission - Version 4
6 May 2023 Submitted Manuscript version 4
13 May 2023 Reviewed Reviewer Report - Magda H. Abdellattif
17 May 2023 Reviewed Reviewer Report
23 May 2023 Reviewed Reviewer Report
1 Jul 2023 Author responded Author comments - Dalia Abdelhamid
Resubmission - Version 5
1 Jul 2023 Submitted Manuscript version 5
2 Jul 2023 Author responded Author comments - Dalia Abdelhamid
Resubmission - Version 6
2 Jul 2023 Submitted Manuscript version 6
4 Jul 2023 Author responded Author comments - Dalia Abdelhamid
Resubmission - Version 7
4 Jul 2023 Submitted Manuscript version 7
Publishing
10 Jul 2023 Editorially accepted
16 Sep 2023 Article published 10.1186/s13065-023-01003-3

You can find further information about peer review here.

Back to article page